Literature DB >> 6777857

Increased plasma noradrenaline concentration in patients with chronic obstructive lung disease: relation to haemodynamics and blood gases.

J H Henriksen, N J Christensen, A Kok-Jensen, I Christiansen.   

Abstract

Nine patients with chronic obstructive lung disease underwent right heart catheterization. Mean pulmonary arterial pressure was elevated, but none of the patients had clinical signs of cardiac failure. Mean arterial oxygen saturation and carbon dioxide tension were 89% and 47 mmHg, respectively. Plasma noradrenaline (NA) concentration averaged 0.51 ng/ml and was inversely correlated to arterial oxygen saturation and mixed venous oxygen saturation, and positively correlated to arterial carbon dioxide tension and mean pulmonary arterial pressure. Oxygen inhalation did not change plasma NA significantly. Eight months later, plasma NA was increased (mean 0.89 ng/ml), as compared to the first determination (P < 0.02), and to a group of normal subjects (mean 0.26 ng/ml, P < 0.005). Inverse correlation to arterial oxygen saturation and direct correlation to arterial carbon dioxide tension were still present. Plasma adrenaline concentration was normal. The results point to enhanced sympathetic nervous activity in patients with chronic obstructive lung disease, probably caused by the deranged blood gases. The pulmonary haemodynamic changes and increased pulse rate may, at least partly, be due to enhanced sympathetic nervous activity.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6777857     DOI: 10.3109/00365518009101864

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  5 in total

Review 1.  Renal and hormonal abnormalities in chronic obstructive pulmonary disease (COPD).

Authors:  P Palange
Journal:  Thorax       Date:  1998-11       Impact factor: 9.139

2.  Impaired adrenergic- and corticotropic-axis outflow during exercise in chronic obstructive pulmonary disease.

Authors:  Ali Iranmanesh; Dudley F Rochester; Jing Liu; Johannes D Veldhuis
Journal:  Metabolism       Date:  2011-05-31       Impact factor: 8.694

3.  Splanchnic and renal elimination and release of catecholamines in cirrhosis. Evidence of enhanced sympathetic nervous activity in patients with decompensated cirrhosis.

Authors:  J H Henriksen; H Ring-Larsen; I L Kanstrup; N J Christensen
Journal:  Gut       Date:  1984-10       Impact factor: 23.059

Review 4.  Sympathetic and Vagal Nerve Activity in COPD: Pathophysiology, Presumed Determinants and Underappreciated Therapeutic Potential.

Authors:  Jens Spiesshoefer; Binaya Regmi; Matteo Maria Ottaviani; Florian Kahles; Alberto Giannoni; Chiara Borrelli; Claudio Passino; Vaughan Macefield; Michael Dreher
Journal:  Front Physiol       Date:  2022-06-23       Impact factor: 4.755

5.  Alterations in isoprenaline sensitivity in patients with cirrhosis: evidence of abnormality of the sympathetic nervous activity.

Authors:  M J Ramond; E Comoy; D Lebrec
Journal:  Br J Clin Pharmacol       Date:  1986-02       Impact factor: 4.335

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.